What is fetal hemoglobin?
Fetal hemoglobin (HbF) is the most dominant form of hemoglobin (Hb) in fetuses and persists until birth, at which time the production of adult Hb is upregulated. Both fetal and adult Hb contain alpha () globin chains; however, in adult Hb, the gamma () globin chains are replaced with beta () globin.
Image Credit: Phonlamai Photo / Shutterstock.com
Six months after birth, HbA is the dominant form of Hb, and any conditions which affect Hb become clinically apparent. At six months, HbF comprises less than 5% of the total Hb, and it continues to fall, reaching the adult level of less than 1% by the age of 2.
The switch from fetal to adult Hb production does not occur to completion, nor is it irreversible. All adults retain the capacity to produce some HbF, which steadily declines throughout adult life. The degree to which HbF persists tends to vary greatly between adults, and this variability is under genetic control.
The persistence of relatively high levels of HbF production is not clinically harmful in healthy individuals; however, in patients suffering from conditions that affect the quality of HbA (such as those suffering from sickle cell disease or -thalassemia), the condition can offer an advantage.
High HbF levels confer significant benefits namely milder disease progression and fewer complications. Therefore, HbF has an ameliorating effect, which has prompted several approaches to therapeutic agent production in patients with mutations affecting adult HbA quality. These approaches include, for example, the pharmacological and gene transfer for HbF synthesis reactivation.
The residual HbF in adults is distributed unevenly amongst the red blood cells; cells that contain measurable quantities are referred to as F cells (FC). These typically contain a mean cell volume (MCV) of between 80-90 fl, compared to larger fetal cells with an MCV of approximately 125 fl. Within the FC, HbF only comprises a small portion of the total Hb.
Detection of FC occurs traditionally by an acid illusion method developed by Kleihauer; however, a much more sensitive immunofluorescence-based method uses an anti- globin antibody for use on fixed red blood cell smears, or via fluorescence-activated cell sorting (FACS), following labeling of the intracellular HbF.
Surveys of healthy blood donors across population groups demonstrate that levels of FC and HbF can vary more than 20-fold, and the distribution is both continuous and positively skewed. Furthermore, family studies show levels of HbF tend to be heritable, although the inheritance patterns are not clear. Twin studies show that the correlation between HbF and FC is genetically controlled, with a heritability of 0.89.
Hereditary persistence of fetal hemoglobin is a condition in which levels of HbF persist at levels greater than typically expected (less than 1%). In hereditary persistence of fetal hemoglobin (HPFH), this HbF percentage varies from levels as low as 0.8-1.0% to approximately 30% of the total hemoglobin.
However, the percentage of HbF can climb as high as 100% in homozygotes (individuals with two copies of the affected gene) for delta beta () thalassemia, another form of thalassemia characterized by defective mutations in the chains of hemoglobin.
This condition is inherited in a mendelian fashion and is caused either by large deletions in the gene that controls the subunit for HbA or by point mutations in the promoter (site of gene expression) of the globin genes. The condition is both benign and asymptomatic. The condition is classified as either pancellular / homocellular or heterocellular, based on the hemoglobin distribution pattern.
Pancellular conditions affect all cells, whereas heterocellular conditions affect some cells, and homocellular conditions affect similar groups of cells. In heterocellular HPFH, the level of HBF can range from 10 to 40%. On the other hand, the levels of HbF in heterocellular HPFH are only modestly elevated, and levels of hemoglobin are unevenly distributed amongst the red blood cells.
Pathogenic increases in HbF, which are distributed heterogeneously, are associated with drug use, malignancies, and hemoglobinopathies. Drugs such as hydroxyurea and pomalidomide increase HPFH. Trisomy 13, a chromosome disorder, is associated with a switch from HbF to HbA with persistently elevated HbF quantities in the blood.
Some patients with -thalassemia, which is caused by reduced or absent synthesis of the globin chains of hemoglobin which reduces the oxygen-carrying capacity of red blood cells, contain elevated levels of HbF that correlate with the degree of chain deficiency as well as a co-inheritance of thalassemia.
This protects against the deleterious effect of - globin chain precipitation, caused by decreased cell: cell chain ratios, which result in unstable tetramers, which are poor carriers of O2.
Other conditions in which elevated HbF is seen in patients include leukemia, following chemotherapy, as well as in patients treated for severe iron deficiency anemia due to acute blood loss. This occurs as a result of 'stressed' hematopoiesis or erythropoiesis (hemoglobin or red blood cell production, respectively). Patients with inherited bone marrow failure syndromes additionally show altered HbF as part of stressed synthesis blood components.
The benefits of HPFH are most noticeable when it co-exists with sickle cell or thalassemia. These conditions cause diminished oxygen-carrying capacity of red blood cells due to unstable chains that form part of the tetramer of the oxygen-binding hemoglobin. As a result, the production of HbF alleviates this issue, as HbF contains rather than chains, which are affected in adult Hb.
Owing to its ability to alleviate the severity of hemoglobinopathies in thalassemias, hereditary persistence of fetal hemoglobin tends to be selected for in populations in which these disorders are prevalent, such as people of African and Greek descent.
Friedman S, Schwartz. Hereditary persistence of foetal haemoglobin with beta-chain synthesis in cis position (gamma-beta+-HPFH) in a negro family". Nature. 1976 doi:10.1038/259138a0
Patel, S. et al. Inheritance of Hereditary Persistence of Fetal Haemoglobin (HPFH) in a Family of Western Odisha, India. J Clin Diagn Res. 2015. doi: 10.7860/JCDR/2015/12878.6548
Sokolova, A. et al. Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review. Hematology/Oncology and Stem Cell Therapy. doi: 10.1016/j.hemonc.2017.09.003
Collins, F.S. et al. gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5 to the G gamma gene. Proc Natl Acad Sci USA. 1984. doi: 10.1073/pnas.81.15.4894
Thein, S. Discovering the genetics underlying foetal haemoglobin production in adults. British Journal of Haematology. 2009. doi: 10.1111/j.1365-2141.2009.07650.x
Read more:
What is Hereditary Persistence of Fetal Hemoglobin? - News-Medical.net
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
Recent Comments